Gentium (Nasdaq: GENT) narrowed fourth quarter losses as revenue climbed. Shares of the biopharmaceutical leaped $1.54 to $3.83.
Gentium Narrows Losses
April 01, 2010 at 14:38 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.